相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52
Wen-liang Wang et al.
ACTA PHARMACOLOGICA SINICA (2021)
Oxidative stress and Liver X Receptor agonist induce hepatocellular carcinoma in Non-alcoholic steatohepatitis model
Yoshio Shimizu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Identification of a novel non-ATP-competitive protein kinase inhibitor of PGK1 from marine nature products
Yuying Wang et al.
BIOCHEMICAL PHARMACOLOGY (2021)
UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinoma
Junjie Xu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans
Li Che et al.
GUT (2020)
hnRNPU/TrkB Defines a Chromatin Accessibility Checkpoint for Liver Injury and Nonalcoholic Steatohepatitis Pathogenesis
Jing Xiong et al.
HEPATOLOGY (2020)
ATP citrate lyase: A central metabolic enzyme in cancer
Philippe Icard et al.
CANCER LETTERS (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Novel mitochondrion-targeting copper(II) complex induces HK2 malfunction and inhibits glycolysis via Drp1-mediating mitophagy in HCC
Mengmeng Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Structure-Based Design and Identification of FT-2102 (Olutasidenib), a Potent Mutant-Selective IDH1 Inhibitor
Justin A. Caravella et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors
Naohiro Okano et al.
INVESTIGATIONAL NEW DRUGS (2020)
ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK/FBW7/c-Myc axis
Junru Chen et al.
ONCOGENESIS (2020)
The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis
Daqian Xu et al.
NATURE (2020)
FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome
Fuming Li et al.
NATURE CELL BIOLOGY (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
LncRNA TMPO-AS1 aggravates the development of hepatocellular carcinoma via miR-429/GOT1 axis
Xiaolong Liu et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2020)
3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells
Xiaodong Sun et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Long noncoding RNA MSC-AS1 promotes hepatocellular carcinoma oncogenesis via inducing the expression of phosphoglycerate kinase 1
Cong Cao et al.
CANCER MEDICINE (2020)
Cytosolic ME1 integrated with mitochondrial IDH2 supports tumor growth and metastasis
Chang Shao et al.
REDOX BIOLOGY (2020)
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
Monica Mossenta et al.
CANCERS (2020)
A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer
Haojie Jin et al.
ELIFE (2020)
HCAR1/MCT1 Regulates Tumor Ferroptosis through the Lactate-Mediated AMPK-SCD1 Activity and Its Therapeutic Implications
Youbo Zhao et al.
CELL REPORTS (2020)
Fatty-acid-induced FABP5/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells
Jieun Seo et al.
COMMUNICATIONS BIOLOGY (2020)
Drilling for Oil: Tumor-Surrounding Adipocytes Fueling Cancer
Camille Attane et al.
TRENDS IN CANCER (2020)
Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2
Tong Liu et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2020)
Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression
Kuo Du et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)
Overexpression of Pyruvate Dehydrogenase E1α Subunit Inhibits Warburg Effect and Induces Cell Apoptosis Through Mitochondria-Mediated Pathway in Hepatocellular Carcinoma
Jihong Sun et al.
ONCOLOGY RESEARCH (2019)
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
James S. Lally et al.
CELL METABOLISM (2019)
DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway
Xiaohui Wei et al.
PHYTOMEDICINE (2019)
Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells
Lufeng Zheng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex
Renhong Yan et al.
NATURE (2019)
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
Kausik K. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Unraveling the Regulation of Hepatic Gluconeogenesis
Xueping Zhang et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Targeting the untargetable KRAS in cancer therapy
Pingyu Liu et al.
ACTA PHARMACEUTICA SINICA B (2019)
Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma
Lorenza Rimassa et al.
CANCER TREATMENT REVIEWS (2019)
Pharmacologic Inhibition of Epidermal Growth Factor Receptor Suppresses Nonalcoholic Fatty Liver Disease in a Murine Fast-Food Diet Model
Bharat Bhushan et al.
HEPATOLOGY (2019)
Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner
Zhaoyu Qin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway
Hongyan Wu et al.
MOLECULES (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer
Lai Wang et al.
PHYTOMEDICINE (2019)
Epigenetics in cancer therapy and nanomedicine
Annalisa Roberti et al.
CLINICAL EPIGENETICS (2019)
Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids via the ATP-AMPK-mTOR-SREBP1 signaling pathway
Ge Liu et al.
FASEB JOURNAL (2019)
MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma
Zide Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells
Li Wang et al.
ONCOTARGETS AND THERAPY (2019)
GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway
Jianbo Xi et al.
EXPERIMENTAL CELL RESEARCH (2019)
Molecular Functionality of Cytochrome P450 4 (CYP4) Genetic Polymorphisms and Their Clinical Implications
Yazun Bashir Jarrar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Differential contribution of pyruvate carboxylation to anaplerosis and cataplerosis during non-gluconeogenic and gluconeogenic conditions in HepG2 cells
Siriluck Wattanavanitchakorn et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)
Tumor suppressor ZHX2 inhibits NAFLD–HCC progression via blocking LPL-mediated lipid uptake
Zhuanchang Wu et al.
CELL DEATH AND DIFFERENTIATION (2019)
Even Cancer Cells Watch Their Cholesterol!
Romain Riscal et al.
MOLECULAR CELL (2019)
Metabolic regulation of gene expression by histone lactylation
Di Zhang et al.
NATURE (2019)
Metabolic rearrangements in primary liver cancers: cause and consequences
Letizia Satriano et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?
Mark A. Febbraio et al.
CELL METABOLISM (2019)
NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis
Haoyan Guo et al.
CANCER LETTERS (2019)
Novel 1,3,4-Selenadiazole-Containing Kidney-Type Glutaminase Inhibitors Showed Improved Cellular Uptake and Antitumor Activity
Zhao Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Metabolic profiling analysis upon acylcarnitines in tissues of hepatocellular carcinoma revealed the inhibited carnitine shuttle system caused by the downregulated carnitine palmitoyltransferase 2
Xin Lu et al.
MOLECULAR CARCINOGENESIS (2019)
Metformin attenuates hepatoma cell proliferation by decreasing glycolytic flux through the HIF-1α/PFKFB3/PFK1 pathway
La Hu et al.
LIFE SCIENCES (2019)
Targeting glutaminase 1 attenuates sternness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway
Binghua Li et al.
EBIOMEDICINE (2019)
Berberine Inhibits Growth of Liver Cancer Cells by Suppressing Glutamine Uptake
Pengcheng Zhang et al.
ONCOTARGETS AND THERAPY (2019)
TO901317 inhibits the development of hepatocellular carcinoma by LXRα/Glut1 decreasing glycometabolism
Ting Xiong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2019)
Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma
Li Chen et al.
FRONTIERS IN ONCOLOGY (2019)
The SLC transporter in nutrient and metabolic sensing, regulation, and drug development
Yong Zhang et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
Argininosuccinate synthase 1 suppresses cancer cell invasion by inhibiting STAT3 pathway in hepatocellular carcinoma
Xuemei Tao et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2019)
Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake
Kosuke Kaji et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Hepatic glucose-6-phosphatase-α deficiency leads to metabolic reprogramming in glycogen storage disease type Ia
Jun-Ho Cho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Targeting Glutamine Metabolism for Cancer Treatment
Yeon-Kyung Choi et al.
BIOMOLECULES & THERAPEUTICS (2018)
Design, synthesis and biological evaluation of novel spiro-pentacylamides as acetyl-CoA carboxylase inhibitors
Qiangqiang Wei et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Sirtuin signaling controls mitochondrial function in glycogen storage disease type IaKeywords
Jun-Ho Cho et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2018)
Anti-Cancer Effects of Emodin on HepG2 Cells as Revealed by H-1 NMR Based Metabolic Profiling
Yue-Xiao Xing et al.
JOURNAL OF PROTEOME RESEARCH (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Shikonin enhances sensitization of gefitinib against wild-type EGFR non-small cell lung cancer via inhibition PKM2/stat3/cyclinD1 signal pathway
Jian-cai Tang et al.
LIFE SCIENCES (2018)
Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation
Xirui Liu et al.
MOLECULAR CANCER (2018)
Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models
Michael L. Schulte et al.
NATURE MEDICINE (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma
Meng-Xi Liu et al.
ONCOGENE (2018)
Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism
Mingzhu Bai et al.
ONCOGENE (2018)
Genomic Profiling and Metabolic Homeostasis in Primary Liver Cancers
Julian A. Gingold et al.
TRENDS IN MOLECULAR MEDICINE (2018)
Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin
Dannielle DeWaal et al.
NATURE COMMUNICATIONS (2018)
Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer
Yekaterina Y. Zaytseva et al.
Oncotarget (2018)
Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH
Kumiko Shiba et al.
SCIENTIFIC REPORTS (2018)
The Human SLC7A5 (LAT1): The Intriguing Histidine/Large Neutral Amino Acid Transporter and Its Relevance to Human Health
Mariafrancesca Scalise et al.
FRONTIERS IN CHEMISTRY (2018)
Acquired ornithine transcarbamylase deficiency in pediatric and adolescent patients with fibrolamellar hepatocellular carcinoma
Allison L. Bartlett et al.
PEDIATRIC BLOOD & CANCER (2018)
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies
Sandro Nuciforo et al.
CELL REPORTS (2018)
The Oncogenic Role of ARG1 in Progression and Metastasis of Hepatocellular Carcinoma
Jia You et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC
Marcus Grohmann et al.
CELL (2018)
PCK1 Downregulation Promotes TXNRD1 Expression and Hepatoma Cell Growth via the Nrf2/Keap1 Pathway
Lin Tuo et al.
FRONTIERS IN ONCOLOGY (2018)
Elevated G6PD expression contributes to migration and invasion of hepatocellular carcinoma cells by inducing epithelial-mesenchymal transition
Ming Lu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2018)
The Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell Biology
Mariafrancesca Scalise et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma
Misu Lee et al.
YONSEI MEDICAL JOURNAL (2018)
Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2)
Lin Jiao et al.
AUTOPHAGY (2018)
Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis
Kenji Kawai et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Metformin confers risk reduction for developing hepatocellular carcinoma recurrence after liver resection
Kun-Ming Chan et al.
LIVER INTERNATIONAL (2017)
2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells
Minoru Tomizawa et al.
ONCOLOGY LETTERS (2017)
Fatty acid synthase (FASN) as a therapeutic target in breast cancer
Javier A. Menendez et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6
Keane K. Y. Lai et al.
GASTROENTEROLOGY (2017)
Glyceraldehyde-3-Phosphate Dehydrogenase Promotes Liver Tumorigenesis by Modulating Phosphoglycerate Dehydrogenase
Shanshan Liu et al.
HEPATOLOGY (2017)
Encouraging New Uses for Old Drugs
Rachel E. Sachs et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2
Dong Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Establishing the foundation for a novel, first-in-class, fatty acid synthase inhibitor, TVB-2640, for the treatment of NASH
G. Duke et al.
JOURNAL OF HEPATOLOGY (2017)
Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation
Mark Kin Fai Ma et al.
JOURNAL OF HEPATOLOGY (2017)
Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells
Hyo-Jin Kim et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer
Ke Chen et al.
MOLECULAR CANCER (2017)
Glucose feeds the TCA cycle via circulating lactate
Sheng Hui et al.
NATURE (2017)
Fatty acid synthase - Modern tumor cell biology insights into a classical oncology target
Douglas Buckley et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Methyl jasmonate leads to necrosis and apoptosis in hepatocellular carcinoma cells via inhibition of glycolysis and represses tumor growth in mice
Jingjing Li et al.
ONCOTARGET (2017)
Preventive effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic mice
Koki Obara et al.
ONCOTARGET (2017)
Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia
Jun-Ho Cho et al.
PLOS GENETICS (2017)
Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition
Takanori Ohata et al.
CANCER MEDICINE (2017)
MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation
X. Jin et al.
ONCOGENESIS (2017)
Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression
Jing Yang et al.
SCIENTIFIC REPORTS (2017)
mTORC2 Promotes Tumorigenesis via Lipid Synthesis
Yakir Guri et al.
CANCER CELL (2017)
Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death
Sainan Li et al.
BRITISH JOURNAL OF CANCER (2017)
A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product
Maria V. Liberti et al.
CELL METABOLISM (2017)
First in human study of the first-in-class fatty acid synthase (FASN) inhibitor TVB-2640
Gerald Falchook et al.
CANCER RESEARCH (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
Antitumor and chemosensitizing action of 3-bromopyruvate: Implication of deregulated metabolism
Saveg Yadav et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine
Ji Zhang et al.
EMBO JOURNAL (2017)
Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma
Yun-Yong Park et al.
HEPATOLOGY (2016)
Expression of Malic Enzymes in Sebaceous Lesions
Ting-Fu Su et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2016)
Intestinal SGLT1 in metabolic health and disease
Anders Lehmann et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Glutamine transporters in mammalian cells and their functions in physiology and cancer
Yangzom D. Bhutia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Combination therapy with a liver selective acetyl-CoA carboxylase inhibitor ND-654 and sorafenib improves efficacy in the treatment of cirrhotic rats with hepatocellular carcinoma
Lan Wei et al.
CANCER RESEARCH (2016)
Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers
Xiaojing Liu et al.
Cell Metabolism (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans
Fasiha Kanwal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Studies on the biological functions of CPS1 in AFS1 induced hepatocarcinogenesis
Chi Yang et al.
GENE (2016)
Acetyl-Coenzyme A Carboxylase Alpha Promotion of Glucose-Mediated Fatty Acid Synthesis Enhances Survival of Hepatocellular Carcinoma in Mice and Patients
Ming-Da Wang et al.
HEPATOLOGY (2016)
Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transition
Weiping Zhu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Transketolase counteracts oxidative stress to drive cancer development
Iris Ming-Jing Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma
Chung-Yu Ku et al.
ONCOTARGET (2016)
GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma
Hong-Wei Sun et al.
PLOS ONE (2016)
The interplay between cell signalling and the mevalonate pathway in cancer
Peter J. Mullen et al.
NATURE REVIEWS CANCER (2016)
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
Elisabetta Degasperi et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Dysregulated fatty acid metabolism in hepatocellular carcinoma
Mingda Wang et al.
HEPATIC ONCOLOGY (2016)
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
Nissim Hay
NATURE REVIEWS CANCER (2016)
SCD1 negatively regulates autophagy-induced cell death in human hepatocellular carcinoma through inactivation of the AMPK signaling pathway
Guang-Ming Huang et al.
CANCER LETTERS (2015)
cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions
Linchong Sun et al.
CELL RESEARCH (2015)
Isocitrate Dehydrogenase 2 Suppresses the Invasion of Hepatocellular Carcinoma Cells via Matrix Metalloproteinase 9
Guo-Yan Tian et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2015)
PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth
Emily D. Montal et al.
MOLECULAR CELL (2015)
Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions
Alessandra Silvestri et al.
PLOS ONE (2015)
Functional expression of sodium-glucose transporters in cancer
Claudio Scafoglio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Malic enzyme 1 induces epithelial-mesenchymal transition and indicates poor prognosis in hepatocellular carcinoma
Duo Wen et al.
TUMOR BIOLOGY (2015)
Hepatic SirT1-Dependent Gain of Function of Stearoyl-CoA Desaturase-1 Conveys Dysmetabolic and Tumor Progression Functions
Li Qiang et al.
CELL REPORTS (2015)
Lipolysis and lipases in white adipose tissue - An update
Andressa Bolsoni-Lopes et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2015)
Evidence for Heightened Hexokinase II Immunoexpression in Hepatocyte Dysplasia and Hepatocellular Carcinoma
Grace Guzman et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma
Wei-Ren Liu et al.
ONCOTARGET (2015)
Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma
Aritro Nath et al.
SCIENTIFIC REPORTS (2015)
Efficacy and Safety of ETC-1002, a Novel Investigational Low-Density Lipoprotein-Cholesterol-Lowering Therapy for the Treatment of Patients With Hypercholesterolemia and Type 2 Diabetes Mellitus
Maria J. Gutierrez et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Pseudogene CYP4Z2P 3′UTR promotes angiogenesis in breast cancer
Lufeng Zheng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth
Yajuan Gao et al.
CANCER LETTERS (2014)
Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration
Keatdamrong Janpipatkul et al.
CELLULAR SIGNALLING (2014)
Expression of Liver X Receptor Correlates with Intrahepatic Inflammation and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
Sang Bong Ahn et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis
Xuehui Hong et al.
GUT (2014)
SREBP-1 Has a Prognostic Role and Contributes to Invasion and Metastasis in Human Hepatocellular Carcinoma
Chao Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
Matt I. Gross et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Type 2 diabetes as a redox disease
James D. Watson
LANCET (2014)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular carcinoma patients
Huiqing Zhang et al.
MEDICAL ONCOLOGY (2014)
HIF-1-Mediated Suppression of Acyl-CoA Dehydrogenases and Fatty Acid Oxidation Is Critical for Cancer Progression
De Huang et al.
CELL REPORTS (2014)
Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
Shukui Qin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin
Morgan D. Fullerton et al.
NATURE MEDICINE (2013)
The impact of L-type amino acid transporter 1 (LAT1) in human hepatocellular carcinoma
Juan Li et al.
TUMOR BIOLOGY (2013)
Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma
Ruihua Ma et al.
NATURE COMMUNICATIONS (2013)
Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges
Melissa M. Phillips et al.
CANCER RESEARCH AND TREATMENT (2013)
Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma
Bo Zhai et al.
WORLD JOURNAL OF HEPATOLOGY (2013)
Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor Growth
Taro Hitosugi et al.
CANCER CELL (2012)
Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence
Vikas P. Sukhatme et al.
FEBS LETTERS (2012)
The pentose phosphate pathway: An antioxidant defense and a crossroad in tumor cell fate
Chiara Riganti et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma
George P. Kim et al.
INVESTIGATIONAL NEW DRUGS (2012)
Design, Synthesis, and Pharmacological Evaluation of Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl Sulfide 3 (BPTES) Analogs as Glutaminase Inhibitors
Krupa Shukla et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma
Chi-Young Jeong et al.
ONCOLOGY REPORTS (2012)
Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer
Wei Yu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Weibo Luo et al.
CELL (2011)
The Lipogenesis Pathway as a Cancer Target
Hanley N. Abramson
JOURNAL OF MEDICINAL CHEMISTRY (2011)
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
Peng Jiang et al.
NATURE CELL BIOLOGY (2011)
Fatty acid synthase as a potential therapeutic target in cancer
Richard Flavin et al.
FUTURE ONCOLOGY (2010)
Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular Carcinoma A Randomized Trial
Ghassan K. Abou-Alfa et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency
Ana Isabel Martinez et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species
Sawako Suzuki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis
Thomas Amann et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate
Ana Paula Pereira da Silva et al.
BIOCHEMICAL JOURNAL (2009)
Novel roles for GAPDH in cell death and carcinogenesis
A. Colell et al.
CELL DEATH AND DIFFERENTIATION (2009)
The molecular determinants of de novo nucleotide biosynthesis in cancer cells
Xuemei Tong et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases
James P. Hardwick
BIOCHEMICAL PHARMACOLOGY (2008)
Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma
Joan Montero et al.
CANCER RESEARCH (2008)
Chemoembolization Combined with Pravastatin Improves Survival in Patients with Hepatocellular Carcinoma
Hannah Graf et al.
DIGESTION (2008)
A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction
Hailan Liu et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells
Ryan J. O. Dowling et al.
CANCER RESEARCH (2007)
trans-2-phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1
Dawn M. Z. Schmidt et al.
BIOCHEMISTRY (2007)
Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted
S Langbein et al.
BRITISH JOURNAL OF CANCER (2006)
ATP citrate lyase inhibition can suppress tumor cell growth
G Hatzivassiliou et al.
CANCER CELL (2005)
Antitumoral actions of the anti-obesity drug orlistat (Xenical™) in breast cancer cells:: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene
JA Menendez et al.
ANNALS OF ONCOLOGY (2005)
Pyruvate kinase type M2 and its role in tumor growth and spreading
S Mazurek et al.
SEMINARS IN CANCER BIOLOGY (2005)
Selection of DNA aptamers against rat liver X receptors
I Surugiu-Wärnmark et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma
MA Rieger et al.
CANCER RESEARCH (2004)
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
RJ Shaw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Glutamine availability up-regulates expression of the amino acid transporter protein ASCT2 in HepG2 cells and stimulates the ASCT2 promoter
CI Bungard et al.
BIOCHEMICAL JOURNAL (2004)
HIf1 and oxygen sensing in the brain
FR Sharp et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Alcohol and hepatocellular carcinoma
TR Morgan et al.
GASTROENTEROLOGY (2004)
Recent insights into stearoyl-CoA desaturase-1
JM Ntambi et al.
CURRENT OPINION IN LIPIDOLOGY (2003)
Lipoprotein lipase: structure, function, regulation, and role in disease
JR Mead et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2002)
The key role of anaplerosis and cataplerosis for citric acid cycle function
OE Owen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity
JN Thupari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Expression of l-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in liver tumor lesions of rat models
H Ohkame et al.
JOURNAL OF SURGICAL ONCOLOGY (2001)
分享论文
